Skip to main content

Peer Review reports

From: Ethacrynic acid is an inhibitor of human factor XIIIa

Original Submission
12 Aug 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
18 Nov 2021 Reviewed Reviewer Report - Arijit Biswas
20 Jan 2022 Reviewed Reviewer Report
14 Feb 2022 Reviewed Reviewer Report - Nihat Mert
17 Feb 2022 Author responded Author comments - Rami A. Al-Horani
Resubmission - Version 3
17 Feb 2022 Submitted Manuscript version 3
24 Feb 2022 Author responded Author comments - Rami A. Al-Horani
Resubmission - Version 4
24 Feb 2022 Submitted Manuscript version 4
3 Apr 2022 Reviewed Reviewer Report
5 Apr 2022 Author responded Author comments - Rami A. Al-Horani
Resubmission - Version 5
5 Apr 2022 Submitted Manuscript version 5
7 Apr 2022 Author responded Author comments - Rami A. Al-Horani
Resubmission - Version 6
7 Apr 2022 Submitted Manuscript version 6
19 Apr 2022 Author responded Author comments - Rami A. Al-Horani
19 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 7
19 Apr 2022 Submitted Manuscript version 7
20 Apr 2022 Author responded Author comments - Rami A. Al-Horani
Resubmission - Version 8
20 Apr 2022 Submitted Manuscript version 8
6 May 2022 Author responded Author comments - Rami A. Al-Horani
Resubmission - Version 9
6 May 2022 Submitted Manuscript version 9
7 May 2022 Author responded Author comments - Rami A. Al-Horani
Resubmission - Version 10
7 May 2022 Submitted Manuscript version 10
9 May 2022 Author responded Author comments - Rami A. Al-Horani
Resubmission - Version 11
9 May 2022 Submitted Manuscript version 11
18 May 2022 Author responded Author comments - Rami A. Al-Horani
Resubmission - Version 12
18 May 2022 Submitted Manuscript version 12
Publishing
25 May 2022 Editorially accepted
1 Jun 2022 Article published 10.1186/s40360-022-00575-5

You can find further information about peer review here.

Back to article page